Quantcast

Cleaning sponge that requires zero chemicals to remove tough dirt becomes a household favourite 

REVEALED: The 'game-changing' $6 cleaning sponge that promises to banish tough stains in areas all over your home - without any chemicals Scrub Daddy is...
More

    Anthony Weiner is spotted with ex-wife Huma Abedin after his new job is revealed

    Piecing his life back together? Anthony Weiner is spotted with ex-wife Huma Abedin walking their son to school after becoming CEO of firm that...

    Pro-surfer sisters Ellie-Jean Coffey and Holly-Daze Coffey offer explicit OnlyFans style content

    Surfer sisters Ellie-Jean Coffey and Holly-Daze Coffey offer explicit OnlyFans-style content as they launch their 'uncensored' paid websites By Marta Jary For Daily Mail Australia...

    Kanye West ‘has spent over $3 million to gather signatures to make presidential ballot in 15 states’

    Kanye West 'has spent over $3 million to gather signatures to make the presidential ballot in 15 states... but he has been BARRED from...

    Trump says ‘out of respect’ he will wait until after RBG’s funeral to nominate her replacement

    Donald Trump says 'out of respect' he will wait until after Ruth Bader Ginsburg's funeral services to nominate her replacement on Supreme Court and...

    Johnson & Johnson reveals coronavirus vaccine prevents severe illness in hamsters

    Johnson & Johnson reveals its coronavirus shot prevents severe illness in hamsters as the drug giant says human trials will start this month

    • Johnson & Johnson tested its coronavirus vaccine candidate, called Ad26-S.PP, on Syrian golden hamsters
    • Vaccinated hamsters lost less weight and had less virus in their lungs and other organs than unvaccinated hamsters
    • The animals that received the jab didn’t experience severe outcomes such as pneumonia or death 
    • J&J plans to begin phase III testing in the second half of September in more than 60,000 volunteers
    • On Thursday, White House Spokeswoman Kayleigh McEnany said there is no pressure on the FDA from Trump to approve a vaccine before the election

    Johnson & Johnson’s coronavirus vaccine candidate prevented severe illness in a small group of hamsters, the drugmaker said on Thursday. 

    In the pre-clinical study, vaccinated animals lost less weight and had less virus in their lungs and other organs than unvaccinated animals.

    Hamsters that received the vaccine, called Ad26-S.PP, produced neutralizing antibodies, which health experts believe is vital to build immunity against COVID-19.

    What’s more, none of the inoculated hamsters experienced severe outcomes such as pneumonia or death.

    It comes as the White House fervently denied that anyone from the Trump administration is putting political pressure on the US Food and Drug Administration (FDA) to approve a vaccine before the November 3 presidential election. 

    Johnson & Johnson tested its coronavirus vaccine candidate, called Ad26-S.PP, on Syrian golden hamsters. Pictured: A lab technician fills a test tube during research on coronavirus, at Johnson & Johnson subsidiary Janssen Pharmaceutical in Beerse, Belgium, June 2020

    Vaccinated Syrian golden hamsters lost less weight and had less virus in their lungs and other organs than unvaccinated hamsters and didn't experience severe outcomes such as pneumonia or death (file image)

    Vaccinated Syrian golden hamsters lost less weight and had less virus in their lungs and other organs than unvaccinated hamsters and didn’t experience severe outcomes such as pneumonia or death (file image)

    On Thursday, White House Spokeswoman Kayleigh McEnany said there is no pressure on the FDA from Trump to approve a vaccine before the election. Pictured: McEnany holds a news briefing at the White House, Thursday

    On Thursday, White House Spokeswoman Kayleigh McEnany said there is no pressure on the FDA from Trump to approve a vaccine before the election. Pictured: McEnany holds a news briefing at the White House, Thursday

    The company began early-stage human trials in the US and Belgium in July after details of a study in monkeys showed its best-performing vaccine candidate offered strong protection in a single dose. 

    ‘This pre-clinical study further validates our confidence in our SARS-CoV-2 vaccine candidate,’ Paul Stoffels, Chief Scientific Officer for J&J, said in a statement, according to CNBC.

    ‘With our Phase 3 trials planned to start this month, we remain committed to expanding our manufacturing and distribution capabilities to enable global access to our SARS-CoV-2 vaccine candidate should it prove to be safe and effective in humans.’  

    In the study, published in the journal Nature Medicine, Syrian golden hamsters, which are more susceptible to diseases than monkeys, were vaccinated and then exposed to the coronavirus after four weeks.

    The researchers found low levels of antibodies that can neutralize the virus were tied to high levels of weight loss.

    Additionally, viral loads decreased from day two of infection to day seven.

    ‘Our data demonstrate that a single immunization of Ad26-S.PP provides robust protection against severe clinical disease after high-dose SARS-CoV-2 infection in hamsters,’ the authors wrote.

    Depending on data from the early-stage human trial, J&J plans to begin phase III testing in the second half of September in more than 60,000 people.

    The late-stage trial will be conducted at 180 locations in the US and at least eight other countries including Brazil, Chile, the Philippines and South Africa.

    In the US, locations will be in 28 states such as California, Florida, Texas, the states with the most overall cases and among the highest transmission rates. 

    J&J’s vaccine combines genetic material from the new virus with the genes of the adenovirus – which causes the common cold – to induce an immune response.

    It is the same technology the company used to make an experimental Ebola vaccine for people in the Democratic Republic of Congo in late 2019.

    According to the World Health Organization, there are more than 170 vaccines in various stages of development with about 30 in human trials.

    None have been authorized yet except for one in Russia, but this was done before large-scale trials were conducted.

    On Thursday, White House Spokeswoman Kayleigh McEnany said there is no political pressure on the FDA to quickly approve a coronavirus immunization.

    This is after it was revealed that the Centers for Disease Control and Prevention suggested a jab could be ready just ahead of the November presidential election. 

    ‘No one is pressuring the FDA to do anything. his is again a bizarre theory spun up by CNN among others,’ McEnany said.

    She said President Donald Trump wants to push through regulatory barriers as quickly as possible, but not at the cost of safety. 

    ‘But he will not in any way sacrifice safety and making sure that is 100 percent airtight for the American people to receive it,’ McEnany said.

    ‘So, the priority here is saving lives, safety, and there will be a safe and effective vaccine in the works.’ 

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    Oregon sheriff deputies make 21 arrests as wildfires ravage through the state 

    Oregon sheriff's office made 21 arrests in two weeks as looters and thieves ransack homes evacuated by residents because of the state's historic wildfires Clackamas...

    Pompeo’s Quest to Redefine Human Rights Draws Concern at U.N.

    WASHINGTON — Secretary of State Mike Pompeo is trying to drum up support at the United Nations for a new vision of human rights...

    Betty Bushman, an Early Female Baseball Voice, Dies at 89

    Betty Bushman had been a model and a television weather forecaster when Charles O. Finley, the cantankerous owner of the Kansas City Athletics, asked...

    Former drug addicts share photos of their incredible transformations before and after recovery

    'I thought I'd be dead last year...' Ex-drug addicts share eye-opening photos of themselves before and after recovery to prove to others that it...